ReviewJournal of hematology & oncology2014
Homoharringtonine and omacetaxine for myeloid hematological malignancies.
Shuqing Lü et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
88 papers cite itlatest 60 shown
this paperpooled ittrialcites it